Evolve Medical Software Solutions Revenue and Competitors

Centurion, South Africa

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Evolve Medical Software Solutions's estimated annual revenue is currently $2.8M per year.(i)
  • Evolve Medical Software Solutions's estimated revenue per employee is $101,500

Employee Data

  • Evolve Medical Software Solutions has 28 Employees.(i)

Evolve Medical Software Solutions's People

NameTitleEmail/Phone
1
Software Development ManagerReveal Email/Phone
2
Intermediate DeveloperReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$496.3M244510%N/AN/A
#2
$5710M7448%N/A$26.9B
#3
$62.2M3501%$1.3MN/A
#4
$3.5M30N/AN/AN/A
#5
$7.2M55N/AN/AN/A
#6
$4.6M40N/AN/AN/A
#7
$156.4M798N/AN/AN/A
#8
$1.7M19N/AN/AN/A
#9
$166.2M848N/AN/AN/A
#10
$16.2M112N/AN/AN/A
#11
$3.9M34N/AN/AN/A
#12
$16.2M112N/AN/AN/A
#13
$24.4M15320%N/AN/A
#14
$2.9M18N/AN/AN/A
#15
$2.9M18N/AN/AN/A
#16
$0.9M12N/AN/AN/A
#17
$16.1M111N/AN/AN/A
#18
$6.4M91N/AN/AN/A
#19
$1.7M19N/AN/AN/A
#20
$8.2M63N/AN/AN/A
Add Company

What Is Evolve Medical Software Solutions?

keywords:saas

N/A

Total Funding

28

Number of Employees

$2.8M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Evolve Medical Software Solutions News

2022-04-20 - Alcon's SMARTCataract Demonstrates Enhanced Efficiency ...

“We look forward to continuing to evolve the SMARTCataract ... INDUSTRY KEYWORD: SOFTWARE INTERNET OPTICAL MEDICAL SUPPLIES SURGERY HEALTH...

2022-04-17 - Getting started with Direct Care: Designing your dream practice

Values:Provide quality medical care that empowers patients to improve their ... Because you are in control, your schedule can evolve to...

2022-04-17 - Tenet Healthcare sees $139M profit in above-expectations Q1 ...

Tenet Healthcare reports $139M profit, above-expectations EBITDA for Q1 2022 ... As for Conifer, the revenue cycle management and solutions...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.8M2856%N/A
#2
N/A3036%N/A
#3
$3.9M34N/AN/A
#4
N/A3540%N/A
#5
$9.2M3559%N/A